159 related articles for article (PubMed ID: 37819454)
21. In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds.
Fabian E; Gomes C; Birk B; Williford T; Hernandez TR; Haase C; Zbranek R; van Ravenzwaay B; Landsiedel R
Arch Toxicol; 2019 Feb; 93(2):401-416. PubMed ID: 30552464
[TBL] [Abstract][Full Text] [Related]
22. AroER tri-screen is a biologically relevant assay for endocrine disrupting chemicals modulating the activity of aromatase and/or the estrogen receptor.
Chen S; Zhou D; Hsin LY; Kanaya N; Wong C; Yip R; Sakamuru S; Xia M; Yuan YC; Witt K; Teng C
Toxicol Sci; 2014 May; 139(1):198-209. PubMed ID: 24496634
[TBL] [Abstract][Full Text] [Related]
23. Development of a combined method to assess the complex effect of atrazine on sex steroid synthesis in H295R cells.
Háhn J; Szoboszlay S; Krifaton C; Kovács KJ; Ferenczi S; Kriszt B
Chemosphere; 2016 Jul; 154():507-514. PubMed ID: 27085065
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of potential endocrine activity of 2,4-dichlorophenoxyacetic acid using in vitro assays.
Coady KK; Kan HL; Schisler MR; Gollapudi BB; Neal B; Williams A; LeBaron MJ
Toxicol In Vitro; 2014 Aug; 28(5):1018-25. PubMed ID: 24815817
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Computational Model for Androgen Receptor Activity.
Kleinstreuer NC; Ceger P; Watt ED; Martin M; Houck K; Browne P; Thomas RS; Casey WM; Dix DJ; Allen D; Sakamuru S; Xia M; Huang R; Judson R
Chem Res Toxicol; 2017 Apr; 30(4):946-964. PubMed ID: 27933809
[TBL] [Abstract][Full Text] [Related]
26. An assessment of the estrogenic and androgenic properties of tetra- and hexachloronaphthalene by YES/YAS in vitro assays.
Stragierowicz J; Stypuła-Trębas S; Radko L; Posyniak A; Nasiadek M; Klimczak M; Kilanowicz A
Chemosphere; 2021 Jan; 263():128006. PubMed ID: 33297039
[TBL] [Abstract][Full Text] [Related]
27. Screening breeding sites of the common toad (Bufo bufo) in England and Wales for evidence of endocrine disrupting activity.
Pickford DB; Jones A; Velez-Pelez A; Orton F; Iguchi T; Mitsui N; Tooi O
Ecotoxicol Environ Saf; 2015 Jul; 117():7-19. PubMed ID: 25817886
[TBL] [Abstract][Full Text] [Related]
28. Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis.
Wang S; Rijk JC; Besselink HT; Houtman R; Peijnenburg AA; Brouwer A; Rietjens IM; Bovee TF
Toxicol Sci; 2014 Sep; 141(1):78-89. PubMed ID: 24928889
[TBL] [Abstract][Full Text] [Related]
29. Estrogenic and androgenic activity of PCBs, their chlorinated metabolites and other endocrine disruptors estimated with two in vitro yeast assays.
Svobodová K; Placková M; Novotná V; Cajthaml T
Sci Total Environ; 2009 Nov; 407(22):5921-5. PubMed ID: 19716585
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of mixture effects of endocrine active substances in wastewater using CALUX reporter-gene assays.
Pannekens H; Gottschlich A; Hollert H; Dopp E
Int J Hyg Environ Health; 2019 May; 222(4):670-677. PubMed ID: 31129136
[TBL] [Abstract][Full Text] [Related]
31. The ability of the YAS and AR CALUX assays to detect the additive effects of anti-androgenic fungicide mixtures.
Seeger B; Klawonn F; Bekale BN; Steinberg P
Toxicol Lett; 2016 Jan; 241():193-9. PubMed ID: 26602169
[TBL] [Abstract][Full Text] [Related]
32. Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models.
Nelms MD; Antonijevic T; Ring C; Harris DL; Bever RJ; Lynn SG; Williams D; Chappell G; Boyles R; Borghoff S; Edwards SW; Markey K
Front Toxicol; 2024; 6():1346767. PubMed ID: 38694816
[TBL] [Abstract][Full Text] [Related]
33. Several environmental oestrogens are also anti-androgens.
Sohoni P; Sumpter JP
J Endocrinol; 1998 Sep; 158(3):327-39. PubMed ID: 9846162
[TBL] [Abstract][Full Text] [Related]
34. Selected bisphenols and phthalates screened for estrogen and androgen disruption by in silico and in vitro methods.
Dvorakova M; Kejlová K; Rucki M; Jírová D
Neuro Endocrinol Lett; 2018 Dec; 39(5):409-416. PubMed ID: 30664347
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of androgen assay results using a curated Hershberger database.
Kleinstreuer NC; Browne P; Chang X; Judson R; Casey W; Ceger P; Deisenroth C; Baker N; Markey K; Thomas RS
Reprod Toxicol; 2018 Oct; 81():272-280. PubMed ID: 30205137
[TBL] [Abstract][Full Text] [Related]
36. Alternative methods in vitro for screening of endocrine disruptors.
Dvořáková M; Kejlová K; Bendová H; Rucki M; Kohout P; Vavrouš A; Jírová D
Neuro Endocrinol Lett; 2016 Dec; 37(Suppl1):123-131. PubMed ID: 28263540
[TBL] [Abstract][Full Text] [Related]
37. Structure-based discovery of the endocrine disrupting effects of hydraulic fracturing chemicals as novel androgen receptor antagonists.
Tachachartvanich P; Azhagiya Singam ER; Durkin KA; Smith MT; La Merrill MA
Chemosphere; 2020 Oct; 257():127178. PubMed ID: 32505947
[TBL] [Abstract][Full Text] [Related]
38. Analysis of environmental endocrine disrupting activities in wastewater treatment plant effluents using recombinant yeast assays incorporated with exogenous metabolic activation system.
Li J; Chen M; Wang Z; Ma M; Peng X
Biomed Environ Sci; 2011 Apr; 24(2):132-9. PubMed ID: 21565684
[TBL] [Abstract][Full Text] [Related]
39. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
[TBL] [Abstract][Full Text] [Related]
40. Reliability of the AR-CALUX®In Vitro Method Used to Detect Chemicals with (Anti)Androgen Activity: Results of an International Ring Trial.
Milcamps A; Liska R; Langezaal I; Casey W; Dent M; Odum J
Toxicol Sci; 2021 Oct; 184(1):170-182. PubMed ID: 34165557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
